• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  11/15/2019
Trade Name:  Harvoni
Generic Name or Proper Name (*):  ledipasvir and sofosbuvir
Indications Studied:  Treatment of chronic hepatitis C virus infection in patients with severe renal impairment including patients with end stage renal disease on dialysis
Label Changes Summary:  *In patients with severe renal impairment, including those requiring dialysis, exposures of the inactive metabolite of sofosbuvir are increased. *• No data are available regarding the safety of Harvoni in pediatric patients with renal impairment. *Postmarketing study.
Sponsor:  Gilead Sciences
Therapeutic Category:  Antiviral